REGENXBIO News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.12.24	Apollo Global Management And Workday To Join S&P 500 (RTTNews)
17.09.24	Regenxbio Names Mitchell Chan CFO (RTTNews)
03.09.24	Regenxbio Announces Positive Data From Pivotal Dose Level Of RGX-121 For Hunter Syndrome (RTTNews)
07.03.24	REGENXBIO Prices Upsized Public Offering Of 4.57 Mln Shares At $23/Shr (RTTNews)
07.02.24	REGENXBIO Reports Positive Results From Phase I/II AFFINITY DUCHENNE Trial (RTTNews)
11.04.23	REGENXBIO: FDA Grants Fast Track Designation For RGX-202 (RTTNews)
21.12.22	Regenxbio To Start Phase I/II Study Of RGX-381 In H1 2023 (RTTNews)
31.08.22	Regenxbio Releases Additional Positive Study Data For Its Hunter Syndrome Drug (RTTNews)
08.02.22	REGENXBIO Announces Presentations at the 11th Annual SVB Leerink Global Healthcare Conference (PR Newswire)
04.02.22	REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2022 Conference (PR Newswire)
31.01.22	REGENXBIO Announces Presentations at the 18th Annual WORLDSymposium™ 2022 (PR Newswire)
22.11.21	REGENXBIO Gets FDA's Orphan Drug Designation For RGX-202 (RTTNews)
13.09.21	AbbVie and REGENXBIO Announce Eye Care Collaboration (PR Newswire)
09.08.21	REGENXBIO Reports Second Quarter 2021 Financial Results and Operational Highlights (PR Newswire)
02.08.21	REGENXBIO to Host Conference Call on August 9 to Discuss Second Quarter 2021 Financial Results and Recent Operational Highlights (PR Newswire)
09.06.21	REGENXBIO to Participate in Upcoming Investor Conferences (PR Newswire)
14.05.21	Regenxbio Presents Positive Interim Data From Phase I/II Trial Of RGX-121 For Treatment Of MPS II (RTTNews)
12.06.18	REGENXBIO Receives FDA Fast Track Designation for RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I (PR Newswire)
11.06.18	REGENXBIO Receives $100 Million Accelerated License Payment Due to Acquisition of AveXis by Novartis (PR Newswire)
05.06.18	Netflix To Replace Monsanto In S&P 100; Twitter To Replace Monsanto In S&P 500 (RTTNews)
05.06.18	Netflix Set to Join S&P 100; Twitter to Join S&P 500; REGENXBIO to Join S&P SmallCap 600 (PR Newswire)
29.05.18	Alexandra Glucksmann Joins REGENXBIO Board of Directors (PR Newswire)
15.05.18	REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation (PR Newswire)
09.05.18	REGENXBIO to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference (PR Newswire)
08.05.18	REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights (PR Newswire)
02.05.18	REGENXBIO Receives FDA Fast Track Designation for RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II (PR Newswire)
01.05.18	REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2018 Financial Results and Recent Operational Highlights (PR Newswire)
17.04.18	APVO Walks The Talk, Eleven Bio Gains Over 13%, PADDOCK Data Boosts APLS (RTTNews)
11.04.18	SPPI Shines On NSCLC Data, TNDM Sales Up 42%, TORC Breathes Easy, VRAY Abuzz (RTTNews)
10.04.18	RGNX On Watch, BOLD To Report Data In Q2, ONCE Sparkles, So Long To AVXS (RTTNews)
09.02.18	FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress (RTTNews)
05.01.18	EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO (RTTNews)
02.01.18	KDMN And 10 Other Biotech Stocks You Should Watch This Month (RTTNews)
29.12.17	Statement From GOMG Holdings Ltd On Sale Of Minority Interest In Ballsh Refinery To Delvina Investment Partners Ltd By Owners Sargeant & Abu Naba'a (PR Newswire)
03.10.17	Ultragenyx To Acquire Dimension Therapeutics In Approx. $151 Mln Deal (RTTNews)
26.09.17	ACRX Nearing 'Big Day', No Respite For VSAR, ARDM To Face FDA (RTTNews)
06.09.17	INSM Breathes Easy, XOMA Rises On Analyst Upgrade, CLLS Down On Clinical Hold (RTTNews)
29.08.17	DIMENSION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dimension Therapeutics, Inc. (PR Newswire)
18.08.17	Gainers & Losers Of Aug.17: GTHX, CDTX, KMDA, ACHC, EDIT... (RTTNews)
10.08.17	Gainers & Losers Of Aug.9: NTRA, ACHN, OMER, SGRY, PGNX... (RTTNews)
27.03.17	REGENXBIO Prices Public Offering Of 3.70 Mln Shares At $20.50/Shr (RTTNews)
08.03.17	AXSM Looks To Busy Year Ahead, SUPN Makes Peace Again, ESPR Hits New High (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu REGENXBIO Inc

Aktien Top/Flop

Meistgelesene Nachrichten